Edurant Articles
Germany's G-BA backs Eisai's Halaven; IQWiG finds some added benefit for Eliquis and rilpivirine
23 April 2012
Gilead and Johnson & Johnson get EU backing for HIV drugs Eviplera and Edurant, respectively
29 November 2011
US FDA approves Johnson & Johnson’s novel AIDS drug Edurant; expands use of Pfizer’s Sutent
23 May 2011
Showing 1-3 of 3 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
